SC

Stephen Coutts

LP La Jolla Pharmaceuticals: 12 patents #2 of 29Top 7%
ES Euro-Celtique S.A.: 3 patents #62 of 215Top 30%
UP Usv Pharmaceutical: 2 patents #32 of 61Top 55%
Overall (All Time): #197,057 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
9049955 Smokeless stovetop grilling device 2015-06-09
8720324 Stovetop grilling device 2014-05-13
8151699 Stovetop grilling device 2012-04-10
7836619 Inflatable flag display 2010-11-23
7430849 Conveyor chain pin remover Sanford Fitelson 2008-10-07
7351855 Chemically defined non-polymeric valency platform molecules and conjugates thereof David S. Jones, Douglas Alan Livingston, Lin Yu 2008-04-01
7115581 Chemically-defined non-polymeric valency platform molecules and conjugates thereof David S. Jones, Douglas Alan Livingston, Lin Yu 2006-10-03
6060056 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule Paul A. Barstad, G. Michael Iverson, David S. Jones 2000-05-09
5874552 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides David S. Jones, John P. Hachmann, Michael J. Conrad, Douglas Alan Livingston 1999-02-23
5786512 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides David S. Jones, John P. Hachmann, Michael J. Conrad, Douglas Alan Livingston 1998-07-28
5726329 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides David S. Jones, John P. Hachmann, Michael J. Conrad, Douglas Alan Livingston 1998-03-10
5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof David S. Jones, Douglas Alan Livingston, Lin Yu 1997-05-27
5606047 Chemically-defined non-polymeric valency platform molecules and conjugates thereof David S. Jones, Douglas Alan Livingston, Lin Yu 1997-02-25
5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof David S. Jones, Douglas Alan Livingston, Lin Yu 1996-09-03
5391785 Intermediates for providing functional groups on the 5' end of oligonucleotides David S. Jones, John P. Hachmann, Michael J. Conrad, Douglas Alan Livingston 1995-02-21
RE34630 Substituted isoquinolines and methods of using same T. Scott Shoupe, Lloyd J. Dolby 1994-06-07
5276013 Conjugates of biologically stable polyfunctional molecules and polynucleotides for treating systemic lupus erythematosus Michael J. Conrad 1994-01-04
5162515 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus Michael J. Conrad 1992-11-10
5019573 Substituted dibenzofurans and methods of using same T. Scott Shoupe, David Baker, Elli S. Hand 1991-05-28
4956371 Substituted isoquinolines and methods of using same T. Scott Shoupe, Lloyd J. Dolby 1990-09-11
4579866 Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents David Stevenson, Robert C. Liu, Laurence L. Ho, Howard Jones 1986-04-01
4477446 1-Benzazepines and their pharmaceutical uses Howard Jones 1984-10-16